RUVY ROSE KUTILEK: Open Payments
NPI 1184207771 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 7 payments from 4 companies in 2025. Trend: 2023 $246 · 2024 $498 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $257 |
| AstraZeneca Pharmaceuticals LP | 3 | $149 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Genmab U.S., Inc. | 1 | $14 |
Products named: RYBREVANT, CALQUENCE, BREYANZI, Epkinly.
Industry payments across CA — which companies pay providers there.
